![Daniel Estes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Estes
Directeur/Membre du Conseil chez
Semnur, Inc.
Profil
Daniel J.
Estes is currently Director at Semnur, Inc., Cirius Therapeutics, Inc. (Independent Director since 2017), Lengo Therapeutics, Inc., Inipharm, Inc., Radionetics Oncology, Inc., and General Partner at Frazier Management LLC since 2020.
Former positions include Independent Director at Sierra Oncology, Inc. from 2017 to 2019, Independent Director at Arcutis Biotherapeutics, Inc. from 2017 to 2020, Director at Outpost Medicine, Inc., Director at Sudo Biosciences, Inc., Consultant at McKinsey & Co., Inc. in 2011, Research Assistant at Stanford University in 2003, and Researcher at the University of Michigan from 2004 to 2008.
Education includes an undergraduate degree from Stanford University conferred in 2003 and a doctorate from the University of Michigan conferred in 2008.
Postes actifs de Daniel Estes
| Sociétés | Poste | Début |
|---|---|---|
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical products & distribution, pharmaceuticals and healthcare service sectors. It provides financing for buyout and growth stage capital requirements. | Private Equity Investor | 01/04/2011 |
Semnur, Inc.
 Semnur, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and commercializes non-opioid pain therapies | Directeur/Membre du Conseil | - |
Cirius Therapeutics, Inc.
 Cirius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company that develops therapies | Directeur/Membre du Conseil | 01/03/2017 |
Lengo Therapeutics, Inc.
 Lengo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops small molecule precision therapeutics that target driver mutations in oncology | Directeur/Membre du Conseil | - |
Inipharm, Inc.
 Inipharm, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company that develops therapies for liver and related diseases | Directeur/Membre du Conseil | - |
Radionetics Oncology, Inc.
 Radionetics Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that discovers and develops novel radio therapeutics for the treatment of oncology indications | Directeur/Membre du Conseil | - |
Anciens postes connus de Daniel Estes
| Sociétés | Poste | Fin |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/08/2020 |
| SIERRA ONCOLOGY, INC. | Directeur/Membre du Conseil | 22/11/2019 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | 31/03/2011 |
| ░░░░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Daniel Estes
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
98
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical products & distribution, pharmaceuticals and healthcare service sectors. It provides financing for buyout and growth stage capital requirements. | Finance |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Develops novel therapeutic approaches for cancer and other diseases | Health Technology |
Semnur, Inc.
Semnur, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and commercializes non-opioid pain therapies | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Outpost Medicine, Inc.
 Outpost Medicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in drug development activities | Health Technology |
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company that develops therapies | Health Technology |
Arcutis Biotherapeutics, Inc.
 Arcutis Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunodermatology drug development company | Health Technology |
Lengo Therapeutics, Inc.
Lengo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops small molecule precision therapeutics that target driver mutations in oncology | Health Technology |
Inipharm, Inc.
Inipharm, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company that develops therapies for liver and related diseases | Health Technology |
Sudo Biosciences, Inc.
 Sudo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that designs and develops medicines that target the tyrosine kinase | Health Technology |
Radionetics Oncology, Inc.
Radionetics Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that discovers and develops novel radio therapeutics for the treatment of oncology indications | Health Technology |
